Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol as Adjunctive to Escitalopram in MDD
NCT04069819Completed
- Sponsor
- Sadat City University
- Start
- Aug 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of cilostazol in major depressive disorder (MDD) (2 arms), sponsored by Sadat City University. Primary endpoint: Hamilton Depression Rating Scale at 6 weeks. Started Aug 2019; status: completed.
02
Drugs
cilostazol
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04069819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04069819.